• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肺癌中的循环微RNA:诊断、预后及抗肿瘤治疗疗效预测的前景]

[Circulating microRNAs in lung cancer: prospects for diagnostics, prognosis and prediction of antitumor treatment efficiency].

作者信息

Vlasov V V, Rykova E Iu, Ponomareva A A, Zaporozhchenko I A, Morozkin E S, Cherdyntseva N V, Laktionov P P

出版信息

Mol Biol (Mosk). 2015 Jan-Feb;49(1):55-66.

PMID:25916110
Abstract

The major methods of microRNA extraction from different biological fluids (particularly, serum and plasma), approaches to the analysis of microRNA concentration and composition, normalization methods used in data analysis are outlined in the review. The advantages and disadvantages of the described methodological approaches are being highlighted. Special attention is given to microRNAs, circulating in blood, which could be used as the markers for minimally invasive lung cancer diagnostics, prediction of antitumor treatment efficiency and disease prognosis. Prospects and limitations arising from the evaluation of clinical significance of microRNAs as the potential tumor markers, and emerging as roles of various microRNAs in the pathogenesis of lung cancer become known, are discussed.

摘要

该综述概述了从不同生物流体(尤其是血清和血浆)中提取微小RNA的主要方法、微小RNA浓度和组成的分析方法以及数据分析中使用的标准化方法。文中强调了所述方法的优缺点。特别关注血液中循环的微小RNA,其可作为微创肺癌诊断、抗肿瘤治疗效果预测和疾病预后的标志物。讨论了评估微小RNA作为潜在肿瘤标志物的临床意义所产生的前景和局限性,以及各种微小RNA在肺癌发病机制中所起作用的相关情况。

相似文献

1
[Circulating microRNAs in lung cancer: prospects for diagnostics, prognosis and prediction of antitumor treatment efficiency].[肺癌中的循环微RNA:诊断、预后及抗肿瘤治疗疗效预测的前景]
Mol Biol (Mosk). 2015 Jan-Feb;49(1):55-66.
2
[Molecular-genetic markers in lung cancer diagnostics].[肺癌诊断中的分子遗传标志物]
Mol Biol (Mosk). 2011 Mar-Apr;45(2):203-17.
3
Application of RNA in situ hybridisation for identification of circulating tumour cells.RNA原位杂交在循环肿瘤细胞鉴定中的应用。
J Clin Pathol. 2015 Aug;68(8):669-70. doi: 10.1136/jclinpath-2015-203112. Epub 2015 May 19.
4
Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.无细胞微小 RNA 作为肺癌的诊断、预后和预测生物标志物。
Genes Chromosomes Cancer. 2013 Apr;52(4):356-69. doi: 10.1002/gcc.22032. Epub 2012 Dec 10.
5
Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer.血清微小RNA-210水平在非小细胞肺癌中的预后意义
J Int Med Res. 2013 Oct;41(5):1437-44. doi: 10.1177/0300060513497560. Epub 2013 Sep 24.
6
Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.循环微RNA:非小细胞肺癌个体化治疗的潜在预测生物标志物
Clin Lung Cancer. 2011 Jan;12(1):14-7. doi: 10.3816/CLC.2011.n.001.
7
Isothermally sensitive detection of serum circulating miRNAs for lung cancer diagnosis.用于肺癌诊断的血清循环 miRNA 的等温敏感检测。
Anal Chem. 2013 Dec 3;85(23):11174-9. doi: 10.1021/ac403462f. Epub 2013 Nov 13.
8
Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.直接从血浆中扩增出的循环miR-221是结直肠癌潜在的诊断和预后标志物,且与p53表达相关。
J Gastroenterol Hepatol. 2010 Oct;25(10):1674-80. doi: 10.1111/j.1440-1746.2010.06417.x.
9
Circulating or tissue microRNAs and extracellular vesicles as potential lung cancer biomarkers: a systematic review.循环或组织微小RNA与细胞外囊泡作为潜在的肺癌生物标志物:一项系统综述
Int J Biol Markers. 2018 Jan;33(1):3-9. doi: 10.5301/ijbm.5000307.
10
Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.鉴定血浆 microRNAs 作为肺癌早期检测的新型无创生物标志物。
Eur J Cancer Prev. 2013 Nov;22(6):540-8. doi: 10.1097/CEJ.0b013e32835f3be9.

引用本文的文献

1
Urinary miRNAs: Technical Updates.尿液微小RNA:技术更新
Microrna. 2024;13(2):110-123. doi: 10.2174/0122115366305985240502094814.
2
Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.循环 microRNAs 作为黑色素瘤的诊断生物标志物:系统评价和荟萃分析。
BMC Cancer. 2023 May 8;23(1):414. doi: 10.1186/s12885-023-10891-6.
3
Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance.探讨 ERα 靶向 miRNAs 在激素抵抗的外泌体介导转移中的作用。
Molecules. 2021 Nov 3;26(21):6661. doi: 10.3390/molecules26216661.
4
Isolation of Cell-Free miRNA from Biological Fluids: Influencing Factors and Methods.从生物流体中分离无细胞miRNA:影响因素与方法
Diagnostics (Basel). 2021 May 11;11(5):865. doi: 10.3390/diagnostics11050865.
5
Integrated Analysis of Dysregulated ncRNA and mRNA Expression Profiles in Humans Exposed to Carbon Nanotubes.碳纳米管暴露人群中失调的非编码RNA和信使RNA表达谱的综合分析
PLoS One. 2016 Mar 1;11(3):e0150628. doi: 10.1371/journal.pone.0150628. eCollection 2016.
6
MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment.胆管疾病中的微小RNA:发病机制、诊断与治疗
J Clin Med. 2015 Aug 26;4(9):1688-712. doi: 10.3390/jcm4091688.